Anoumou Y Dagnra
Overview
Explore the profile of Anoumou Y Dagnra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aghokeng A, Ngo-Giang-Huong N, Huynh T, Dagnra A, Toni T, Maiga A, et al.
J Antimicrob Chemother
. 2024 Mar;
79(5):1164-1168.
PMID: 38546752
Objectives: Integrase strand transfer inhibitors (INSTIs) have been recently recommended as the preferred first-line option for antiretroviral treatment initiators in low- and middle-income countries (LMICs) in response to the growing...
2.
Salou M, Zida-Compaore W, Gbeasor-Komlanvi F, Folly-Gbogboe M, Konou A, Dossim S, et al.
Med Trop Sante Int
. 2022 Jun;
1(4).
PMID: 35685859
Aims: Dengue is the most common arbovirus in the world. In Africa, dengue virus is endemic in almost every country; however, in Togo few data are available. The aim of...
3.
Salou M, Butel C, Comlan A, Konou A, Tegueni K, Ehlan A, et al.
AIDS
. 2020 Jan;
34(5):783-787.
PMID: 31895149
Objective: Evaluate the potential effectiveness of the implementation of dolutegravir (DTG)-based regimens in patients on failing current antiretroviral treatment (ART) given the high levels of nucleoside reverse transcriptase inhibitor (NRTI)...
4.
Ngo-Giang-Huong N, Huynh T, Dagnra A, Toni T, Maiga A, Kania D, et al.
J Antimicrob Chemother
. 2018 Nov;
74(2):462-467.
PMID: 30418575
Background: ART in the developing world has moved to a new era with the WHO recommendation to test and immediately treat HIV-positive individuals. A high frequency of pretreatment HIV drug...
5.
Konou A, Vidal N, Salou M, Anato S, Singo-Tokofai A, Ekouevi D, et al.
Infect Genet Evol
. 2016 May;
46:279-285.
PMID: 27235597
Understanding the HIV epidemic in key populations is important. Today only scarce information is available on HIV-1 strains that circulate in men having sex with men (MSM) in sub-Saharan Africa....
6.
Salou M, Butel C, Konou A, Ekouevi D, Vidal N, Dossim S, et al.
Pediatr Infect Dis J
. 2016 May;
35(8):879-85.
PMID: 27167115
Background: Prevention of mother-to-child transmission (PMTCT) programs have been largely scaled-up, but data on infant HIV drug resistance from PMTCT programs implemented in resource-limited countries are lacking. Methods: Remnant dried...
7.
Salou M, Dagnra A, Butel C, Vidal N, Serrano L, Takassi E, et al.
J Int AIDS Soc
. 2016 Apr;
19(1):20683.
PMID: 27125320
Introduction: Antiretroviral treatment (ART) has been scaled up over the last decade but compared to adults, children living with HIV are less likely to receive ART. Moreover, children and adolescents...
8.
Konou A, Salou M, Vidal N, Kodah P, Kombate D, Kpanla P, et al.
AIDS Res Ther
. 2015 Dec;
12:38.
PMID: 26617663
Background: Access to antiretroviral treatment (ART) in resource-limited countries has increased significantly but scaling-up ART into semi-rural and rural areas is more recent. Information on treatment outcome in such areas...
9.
Konou A, Dagnra A, Vidal N, Salou M, Adam Z, Singo-Tokofai A, et al.
AIDS
. 2015 Nov;
29(18):2527-30.
PMID: 26558549
Information on efficacy of long-term antiretroviral treatment (ART) exposure in resource-limited countries is still scarce. In 767 patients attending routine HIV centers in Togo and receiving first-line ART for more...
10.
Tang M, Rhee S, Bertagnolio S, Ford N, Holmes S, Sigaloff K, et al.
J Infect Dis
. 2013 May;
207 Suppl 2:S70-7.
PMID: 23687292
Background: The World Health Organization Antiretroviral Treatment Guidelines recommend phasing-out stavudine because of its risk of long-term toxicity. There are two mutational pathways of stavudine resistance with different implications for...